Cite
ARN-509: a novel antiandrogen for prostate cancer treatment.
MLA
Clegg, Nicola J., et al. “ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment.” Cancer Research, vol. 72, no. 6, Mar. 2012, pp. 1494–503. EBSCOhost, https://doi.org/10.1158/0008-5472.CAN-11-3948.
APA
Clegg, N. J., Wongvipat, J., Joseph, J. D., Tran, C., Ouk, S., Dilhas, A., Chen, Y., Grillot, K., Bischoff, E. D., Cai, L., Aparicio, A., Dorow, S., Arora, V., Shao, G., Qian, J., Zhao, H., Yang, G., Cao, C., Sensintaffar, J., … Hager, J. H. (2012). ARN-509: a novel antiandrogen for prostate cancer treatment. Cancer Research, 72(6), 1494–1503. https://doi.org/10.1158/0008-5472.CAN-11-3948
Chicago
Clegg, Nicola J, John Wongvipat, James D Joseph, Chris Tran, Samedy Ouk, Anna Dilhas, Yu Chen, et al. 2012. “ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment.” Cancer Research 72 (6): 1494–1503. doi:10.1158/0008-5472.CAN-11-3948.